Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns.

Kirby MK, Ramaker RC, Roberts BS, Lasseigne BN, Gunther DS, Burwell TC, Davis NS, Gulzar ZG, Absher DM, Cooper SJ, Brooks JD, Myers RM.

BMC Cancer. 2017 Apr 17;17(1):273. doi: 10.1186/s12885-017-3252-2.

2.

NUSAP1 expression is upregulated by loss of RB1 in prostate cancer cells.

Gordon CA, Gulzar ZG, Brooks JD.

Prostate. 2015 Apr 1;75(5):517-26. doi: 10.1002/pros.22938. Epub 2015 Jan 13.

PMID:
25585568
3.

Novel fusion transcripts associate with progressive prostate cancer.

Yu YP, Ding Y, Chen Z, Liu S, Michalopoulos A, Chen R, Gulzar ZG, Yang B, Cieply KM, Luvison A, Ren BG, Brooks JD, Jarrard D, Nelson JB, Michalopoulos GK, Tseng GC, Luo JH.

Am J Pathol. 2014 Oct;184(10):2840-9. doi: 10.1016/j.ajpath.2014.06.025.

4.

Increased expression of GCNT1 is associated with altered O-glycosylation of PSA, PAP, and MUC1 in human prostate cancers.

Chen Z, Gulzar ZG, St Hill CA, Walcheck B, Brooks JD.

Prostate. 2014 Jul;74(10):1059-67. doi: 10.1002/pros.22826. Epub 2014 May 22.

5.

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Dubai cohort of the A1chieve study.

Gulzar Z, Sharma L, Zachariya T.

Indian J Endocrinol Metab. 2013 Nov;17(Suppl 2):S472-6. doi: 10.4103/2230-8210.122084.

6.

mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer.

Cann GM, Gulzar ZG, Cooper S, Li R, Luo S, Tat M, Stuart S, Schroth G, Srinivas S, Ronaghi M, Brooks JD, Talasaz AH.

PLoS One. 2012;7(11):e49144. doi: 10.1371/journal.pone.0049144. Epub 2012 Nov 7.

7.

Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1.

Gulzar ZG, McKenney JK, Brooks JD.

Oncogene. 2013 Jan 3;32(1):70-7. doi: 10.1038/onc.2012.27. Epub 2012 Feb 20.

8.

Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness.

Huang S, Gulzar ZG, Salari K, Lapointe J, Brooks JD, Pollack JR.

Oncogene. 2012 Sep 13;31(37):4164-70. doi: 10.1038/onc.2011.590. Epub 2011 Dec 19.

9.

DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer.

Kobayashi Y, Absher DM, Gulzar ZG, Young SR, McKenney JK, Peehl DM, Brooks JD, Myers RM, Sherlock G.

Genome Res. 2011 Jul;21(7):1017-27. doi: 10.1101/gr.119487.110. Epub 2011 Apr 26.

10.
11.

Nurse-led cancer genetics clinics in primary and secondary care in varied ethnic population areas: interaction with primary care to improve ascertainment of individuals from ethnic minorities.

Gulzar Z, Goff S, Njindou A, Hearty H, Rafi I, Savage R, Matta G, Ferras J, Hodgson S.

Fam Cancer. 2007;6(2):205-12. Epub 2007 May 17.

PMID:
17508270
12.

Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder.

Khan AA, Abel PD, Chaudhary KS, Gulzar Z, Stamp GW, Lalani EN.

Mol Pathol. 2003 Dec;56(6):353-61.

13.

Cerebral involvement in benign tertian malaria.

Beg MA, Khan R, Baig SM, Gulzar Z, Hussain R, Smego RA Jr.

Am J Trop Med Hyg. 2002 Sep;67(3):230-2.

PMID:
12408660
14.

Neck and whole-body scanning with 5-mCi dose of (123)I as diagnostic tracer in patients with well-differentiated thyroid cancer.

Gulzar Z, Jana S, Young I, Bukberg P, Yen V, Naddaf S, Abdel-Dayem HM.

Endocr Pract. 2001 Jul-Aug;7(4):244-9.

PMID:
11497474

Supplemental Content

Loading ...
Support Center